There was also a 65% relative reduction in COVID-related medical visits (95% CI 24.4-83.8) with nirmatrelvir-ritonavir versus ...

A higher possibility of finding viruses that cause Covid-19 was linked to patients who had taken the antiviral drugs.

Paxlovid significantly shortened the time to symptom relief (median, 13 vs 15 days; hazard ratio [HR], 1.27) and resolution (16 vs 19 days; HR, 1.20) through 28 days and cut the number of ...

The former public health official who filed a whistleblower complaint against the Trump administration is ringing the alarm ...

Onconova Therapeutics Inc ( (TRAW) ) has released its Q3 earnings. Here is a breakdown of the information Onconova Therapeutics Inc presented ...

He contracted the coronavirus because he was an out-front leader and he "had to do that ... Trump doctor on the president's ...

The virus takes control of three key host proteins that suppress the activity of the complement system. Researchers at the ...

Business which accounts for close to one-third of group sales also took in €437m in dividends from subsidiaries dotted ...

Researchers from the IBB-UAB have developed a new class of nanostructures capable of trapping and neutralising large quantities of the SARS-CoV2 virus ...

SHELTON, CT / ACCESSWIRE / November 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the quarter ending September 30 ...

BOTHELL, Wash., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) reports financial results for the three and nine months ended September 30, 2024, ...

Chatham-Kent health agencies urge the public to take advantage of the flu and COVID-19 vaccines and RSV (respiratory ...